Market overview
The global biosafety cabinet market is worth USD 958 mn in 2026 and is forecast to reach USD 1.9 bn by 2036, growing at a 7.0% CAGR. United States is the largest country market and Class II type A2 is the largest by class segment.
| Scope | Ventilated enclosures with HEPA filtered airflow that protect operators and samples when handling biological agents, class I, II and III cabinets, sold to laboratories, hospitals and pharmaceutical sites. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 900 mn |
| Value 2026 | USD 958 mn |
| Value 2036 | USD 1.9 bn |
| CAGR 2026-2036 | 7.0% |
| Volume 2026 | 65,054 units |
| Volume 2036 | 110,269 units |
| Average price 2026 | USD 14,730 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Biosafety Cabinet market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 958.5 mn |
| 2027 | USD 1.03 bn |
| 2028 | USD 1.10 bn |
| 2029 | USD 1.17 bn |
| 2030 | USD 1.26 bn |
| 2031 | USD 1.34 bn |
| 2032 | USD 1.44 bn |
| 2033 | USD 1.54 bn |
| 2034 | USD 1.65 bn |
| 2035 | USD 1.76 bn |
| 2036 | USD 1.89 bn |
Biosafety Cabinet market segmentation
By class
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Class II type A2 | 58.0% | 58.1% | USD 556 mn | 7.0% |
| Class II type B2 | 14.0% | 13.4% | USD 134 mn | 6.5% |
| Class I | 12.0% | 10.4% | USD 115 mn | 5.5% |
| Class III and glove box | 8.0% | 9.2% | USD 77 mn | 8.5% |
| Pharmacy and other | 8.0% | 8.8% | USD 77 mn | 8.0% |
By end user
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharmaceutical and biotech | 32.0% | 35.6% | USD 307 mn | 8.2% |
| Hospitals and clinics | 22.0% | 20.3% | USD 211 mn | 6.1% |
| Academic and research | 26.0% | 24.0% | USD 249 mn | 6.1% |
| Government and public health | 12.0% | 11.6% | USD 115 mn | 6.6% |
| Diagnostics | 8.0% | 8.5% | USD 77 mn | 7.7% |
By airflow design
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Recirculating air | 50.0% | 48.0% | USD 479 mn | 6.6% |
| Exhaust air | 30.0% | 30.0% | USD 288 mn | 7.0% |
| Ducted | 20.0% | 22.0% | USD 192 mn | 8.0% |
By width
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Up to 4 ft | 30.0% | 28.0% | USD 288 mn | 6.3% |
| 4 to 6 ft | 50.0% | 50.0% | USD 479 mn | 7.0% |
| Above 6 ft | 20.0% | 22.0% | USD 192 mn | 8.0% |
By application
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Clinical diagnostics | 34.0% | 33.0% | USD 326 mn | 6.7% |
| Pharma and biotech | 30.0% | 31.0% | USD 288 mn | 7.3% |
| Academic research | 24.0% | 22.0% | USD 230 mn | 6.1% |
| Public health labs | 12.0% | 14.0% | USD 115 mn | 8.7% |
Top 25 countries for biosafety cabinet by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 81.5% of 2026 revenue and the 25 countries below together hold 94.3%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 288 mn | 30.0% | USD 517 mn | 6.0% |
| 2 | China | USD 153 mn | 16.0% | USD 381 mn | 9.5% |
| 3 | Germany | USD 67 mn | 7.0% | USD 115 mn | 5.5% |
| 4 | Japan | USD 58 mn | 6.0% | USD 94 mn | 5.1% |
| 5 | United Kingdom | USD 43 mn | 4.5% | USD 74 mn | 5.5% |
| 6 | India | USD 43 mn | 4.5% | USD 113 mn | 10.1% |
| 7 | France | USD 38 mn | 4.0% | USD 66 mn | 5.6% |
| 8 | South Korea | USD 34 mn | 3.5% | USD 66 mn | 7.0% |
| 9 | Italy | USD 29 mn | 3.0% | USD 49 mn | 5.5% |
| 10 | Brazil | USD 29 mn | 3.0% | USD 60 mn | 7.7% |
| 11 | Spain | USD 17 mn | 1.8% | USD 33 mn | 6.8% |
| 12 | Netherlands | USD 15 mn | 1.6% | USD 29 mn | 6.8% |
| 13 | Australia | USD 15 mn | 1.6% | USD 28 mn | 6.7% |
| 14 | Canada | USD 12 mn | 1.2% | USD 23 mn | 6.7% |
| 15 | Belgium | USD 9.6 mn | 1.0% | USD 18 mn | 6.8% |
| 16 | Singapore | USD 9.4 mn | 1.0% | USD 20 mn | 8.0% |
| 17 | Saudi Arabia | USD 8.9 mn | 0.9% | USD 19 mn | 8.0% |
| 18 | Mexico | USD 6.5 mn | 0.7% | USD 14 mn | 8.1% |
| 19 | Russia | USD 6.1 mn | 0.6% | USD 13 mn | 8.0% |
| 20 | Poland | USD 5.7 mn | 0.6% | USD 12 mn | 8.0% |
| 21 | Sweden | USD 4.9 mn | 0.5% | USD 9.2 mn | 6.6% |
| 22 | Switzerland | USD 4.2 mn | 0.4% | USD 8.1 mn | 6.8% |
| 23 | Taiwan | USD 3.1 mn | 0.3% | USD 6.6 mn | 8.0% |
| 24 | Thailand | USD 2.5 mn | 0.3% | USD 5.3 mn | 7.8% |
| 25 | Turkey | USD 2.4 mn | 0.2% | USD 5.3 mn | 8.2% |
| Rest of world | USD 55 mn | 5.7% | USD 105 mn | 6.7% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Thermo Fisher Scientific
- Esco Lifesciences
- Haier Biomedical
- Labconco
Group 2: Regional and specialist players
- The Baker Company
- NuAire
- Telstar
- Kewaunee Scientific
- Berner International
Group 3: Emerging and niche players
- Air Science
- Biobase
- Germfree
- Heal Force
- Bigneat
- Faster Srl
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the biosafety cabinet market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.0% is calculated from the resulting values.
The market is divided by class, by end user, by airflow design, by width, by application. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the biosafety cabinet market?
The global biosafety cabinet market is estimated at USD 900 mn in 2025 and USD 958 mn in 2026.
How fast will the biosafety cabinet market grow?
It is forecast to reach USD 1.9 bn by 2036, a compound annual growth rate of 7.0% from 2026, an increase of USD 927 mn.
Which country is the largest market for biosafety cabinet?
United States is the largest market by revenue at USD 288 mn in 2026, 30.0% of the global total. The three largest countries together hold 53.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 10.1% a year from 2026 to 2036.
Which biosafety cabinet segment is largest?
In the by class split, Class II type A2 is the largest segment with 58.0% of 2026 revenue.
Who are the leading biosafety cabinet companies?
Global leaders include Thermo Fisher Scientific, Esco Lifesciences, Haier Biomedical, Labconco.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Digital Twins TechnologiesUSD 967 mn · 21.0% CAGR
- Glioblastoma Treatment DrugsUSD 945 mn · 5.5% CAGR
- Robotic Catheterization SystemsUSD 944 mn · 15.0% CAGR
- Epilepsy Monitoring DevicesUSD 942 mn · 7.5% CAGR
- Endoluminal & Bronchoscopy RobotsUSD 976 mn · 17.0% CAGR
- Comparator SourcingUSD 976 mn · 8.5% CAGR
- Virus InactivationUSD 935 mn · 10.0% CAGR
- Early Pulmonary Embolism Thrombectomy DeviceUSD 935 mn · 12.0% CAGR